Department of Microbiology and Immunology, Gifu Pharmaceutical University, 1-25-4 Daigaku Nishi, Gifu 501-1196, Japan.
Department of Microbiology and Immunology, Gifu Pharmaceutical University, 1-25-4 Daigaku Nishi, Gifu 501-1196, Japan.
Vaccine. 2020 Apr 9;38(17):3330-3338. doi: 10.1016/j.vaccine.2020.02.084. Epub 2020 Mar 17.
Lactic acid bacteria have been studied as a vehicle for the delivery of plasmid DNA to the gastrointestinal tract. However, low levels of gene expression in vivo limit their practical use. Furthermore, it is still unclear how the orally administrated bacteria transfer their harbored plasmid DNA to host intestinal cells. To more easily track the delivery of plasmid DNA for eukaryotic expression in the intestine, we constructed an L. lactis-E. coli shuttle plasmid (pLEC) that allowed significantly elevated expression of the target protein of interest in eukaryotic cells. We first demonstrated its usefulness for delivery from L. lactis to Caco-2 cells in vitro. We then investigated the cellular target for the L. lactis DNA delivery system in vivo. Mice were orally administrated with LL/pLEC:EGFP, an L. lactis strain carrying pLEC for EGFP expression, and immunofluorescent analyses of frozen sections prepared from their small intestines identified a number of EGFP-expressing cells in the lamina propria and some in the sub-epithelial dome of the Peyer's patches. Flow cytometric analysis revealed that these EGFP-expressing cells were both CD11c- and F4/80-positive but CXCR1-negative, suggesting that they are eosinophils. Immunostaining of the sections with an antibody against Siglec-F, a marker protein of eosinophils, confirmed the flow cytometric findings. Thus, the target cells of DNA delivery from L. lactis in the intestines are mainly eosinophils in the lamina propria and Peyer's patches. This finding may open a new approach to the development of DNA vaccines for oral administration.
乳酸菌已被研究作为将质粒 DNA 递送至胃肠道的载体。然而,体内低水平的基因表达限制了它们的实际应用。此外,口服细菌如何将其携带的质粒 DNA 转移至宿主肠细胞仍不清楚。为了更方便地跟踪在肠道中进行真核表达的质粒 DNA 的传递,我们构建了一种乳链菌-大肠杆菌穿梭质粒(pLEC),可显著提高真核细胞中感兴趣的靶蛋白的表达。我们首先证明了其在体外从乳链菌向 Caco-2 细胞传递的有用性。然后,我们在体内研究了乳链菌 DNA 传递系统的细胞靶标。通过口服给予携带 pLEC 用于 EGFP 表达的乳链菌 LL/pLEC:EGFP,对从小肠制备的冷冻切片进行免疫荧光分析,在固有层和派尔氏斑的一些上皮下穹窿中鉴定出许多表达 EGFP 的细胞。流式细胞术分析表明,这些表达 EGFP 的细胞均为 CD11c-和 F4/80-阳性,但 CXCR1-阴性,表明它们是嗜酸性粒细胞。用针对 Siglec-F 的抗体对切片进行免疫染色,Siglec-F 是嗜酸性粒细胞的标记蛋白,证实了流式细胞术的发现。因此,乳链菌在肠道中进行 DNA 传递的靶细胞主要是固有层和派尔氏斑中的嗜酸性粒细胞。这一发现可能为口服 DNA 疫苗的开发开辟新途径。